Aclidinio bromuro (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Aclidinio bromuro" in Italian language version.

refsWebsite

Global rank Italian rank

8nih.gov

4^th place

9^th place

7oadoi.org

799^th place

22^nd place

7doi.org

2^nd place

7^th place

doi.org

dx.doi.org

Cazzola M, Page CP, Matera MG, Aclidinium bromide for the treatment of chronic obstructive pulmonary disease, in Expert Opin Pharmacother, vol. 14, n. 9, giugno 2013, pp. 1205–14, DOI:10.1517/14656566.2013.789021, PMID 23566013.
Malerba M, Radaeli A, Santini G, Morjaria J, Mores N, Mondino C, Macis G, Montuschi P, The discovery and development of aclidinium bromide for the treatment of chronic obstructive pulmonary disease, in Expert Opin Drug Discov, vol. 13, n. 6, giugno 2018, pp. 563–577, DOI:10.1080/17460441.2018.1455661, PMID 29616842.
Gavaldà A, Miralpeix M, Ramos I, Otal R, Carreño C, Viñals M, Doménech T, Carcasona C, Reyes B, Vilella D, Gras J, Cortijo J, Morcillo E, Llenas J, Ryder H, Beleta J, Characterization of aclidinium bromide, a novel inhaled muscarinic antagonist, with long duration of action and a favorable pharmacological profile, in J Pharmacol Exp Ther, vol. 331, n. 2, novembre 2009, pp. 740–51, DOI:10.1124/jpet.109.151639, PMID 19710368.
Gavaldà A, Gras J, Llupià J, Aubets J, Beleta J, Llenas J, Aclidinium bromide, a novel long-acting muscarinic antagonist for COPD with improved preclinical renal and urinary safety profile, in Life Sci, vol. 90, n. 7-8, febbraio 2012, pp. 301–5, DOI:10.1016/j.lfs.2011.12.002, PMID 22213116.
Belmonte KE, Cholinergic pathways in the lungs and anticholinergic therapy for chronic obstructive pulmonary disease, in Proc Am Thorac Soc, vol. 2, n. 4, 2005, pp. 297–304; discussion 311–2, DOI:10.1513/pats.200504-043SR, PMID 16267352.
Albertí J, Martinet A, Sentellas S, Salvà M, Identification of the human enzymes responsible for the enzymatic hydrolysis of aclidinium bromide, in Drug Metab Dispos, vol. 38, n. 7, luglio 2010, pp. 1202–10, DOI:10.1124/dmd.109.031724, PMID 20332199.
Sentellas S, Ramos I, Albertí J, Salvà M, Antón F, Miralpeix M, Beleta J, Gavaldà A, Aclidinium bromide, a new, long-acting, inhaled muscarinic antagonist: in vitro plasma inactivation and pharmacological activity of its main metabolites, in Eur J Pharm Sci, vol. 39, n. 5, marzo 2010, pp. 283–90, DOI:10.1016/j.ejps.2010.01.004, PMID 20093184.

nih.gov

ncbi.nlm.nih.gov

Cazzola M, Page CP, Matera MG, Aclidinium bromide for the treatment of chronic obstructive pulmonary disease, in Expert Opin Pharmacother, vol. 14, n. 9, giugno 2013, pp. 1205–14, DOI:10.1517/14656566.2013.789021, PMID 23566013.
Malerba M, Radaeli A, Santini G, Morjaria J, Mores N, Mondino C, Macis G, Montuschi P, The discovery and development of aclidinium bromide for the treatment of chronic obstructive pulmonary disease, in Expert Opin Drug Discov, vol. 13, n. 6, giugno 2018, pp. 563–577, DOI:10.1080/17460441.2018.1455661, PMID 29616842.
Gavaldà A, Miralpeix M, Ramos I, Otal R, Carreño C, Viñals M, Doménech T, Carcasona C, Reyes B, Vilella D, Gras J, Cortijo J, Morcillo E, Llenas J, Ryder H, Beleta J, Characterization of aclidinium bromide, a novel inhaled muscarinic antagonist, with long duration of action and a favorable pharmacological profile, in J Pharmacol Exp Ther, vol. 331, n. 2, novembre 2009, pp. 740–51, DOI:10.1124/jpet.109.151639, PMID 19710368.
Gavaldà A, Gras J, Llupià J, Aubets J, Beleta J, Llenas J, Aclidinium bromide, a novel long-acting muscarinic antagonist for COPD with improved preclinical renal and urinary safety profile, in Life Sci, vol. 90, n. 7-8, febbraio 2012, pp. 301–5, DOI:10.1016/j.lfs.2011.12.002, PMID 22213116.
Belmonte KE, Cholinergic pathways in the lungs and anticholinergic therapy for chronic obstructive pulmonary disease, in Proc Am Thorac Soc, vol. 2, n. 4, 2005, pp. 297–304; discussion 311–2, DOI:10.1513/pats.200504-043SR, PMID 16267352.
Caulfield MP, Birdsall NJ, International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors, in Pharmacol Rev, vol. 50, n. 2, giugno 1998, pp. 279–90, PMID 9647869.
Albertí J, Martinet A, Sentellas S, Salvà M, Identification of the human enzymes responsible for the enzymatic hydrolysis of aclidinium bromide, in Drug Metab Dispos, vol. 38, n. 7, luglio 2010, pp. 1202–10, DOI:10.1124/dmd.109.031724, PMID 20332199.
Sentellas S, Ramos I, Albertí J, Salvà M, Antón F, Miralpeix M, Beleta J, Gavaldà A, Aclidinium bromide, a new, long-acting, inhaled muscarinic antagonist: in vitro plasma inactivation and pharmacological activity of its main metabolites, in Eur J Pharm Sci, vol. 39, n. 5, marzo 2010, pp. 283–90, DOI:10.1016/j.ejps.2010.01.004, PMID 20093184.

oadoi.org

Cazzola M, Page CP, Matera MG, Aclidinium bromide for the treatment of chronic obstructive pulmonary disease, in Expert Opin Pharmacother, vol. 14, n. 9, giugno 2013, pp. 1205–14, DOI:10.1517/14656566.2013.789021, PMID 23566013.
Malerba M, Radaeli A, Santini G, Morjaria J, Mores N, Mondino C, Macis G, Montuschi P, The discovery and development of aclidinium bromide for the treatment of chronic obstructive pulmonary disease, in Expert Opin Drug Discov, vol. 13, n. 6, giugno 2018, pp. 563–577, DOI:10.1080/17460441.2018.1455661, PMID 29616842.
Gavaldà A, Miralpeix M, Ramos I, Otal R, Carreño C, Viñals M, Doménech T, Carcasona C, Reyes B, Vilella D, Gras J, Cortijo J, Morcillo E, Llenas J, Ryder H, Beleta J, Characterization of aclidinium bromide, a novel inhaled muscarinic antagonist, with long duration of action and a favorable pharmacological profile, in J Pharmacol Exp Ther, vol. 331, n. 2, novembre 2009, pp. 740–51, DOI:10.1124/jpet.109.151639, PMID 19710368.
Gavaldà A, Gras J, Llupià J, Aubets J, Beleta J, Llenas J, Aclidinium bromide, a novel long-acting muscarinic antagonist for COPD with improved preclinical renal and urinary safety profile, in Life Sci, vol. 90, n. 7-8, febbraio 2012, pp. 301–5, DOI:10.1016/j.lfs.2011.12.002, PMID 22213116.
Belmonte KE, Cholinergic pathways in the lungs and anticholinergic therapy for chronic obstructive pulmonary disease, in Proc Am Thorac Soc, vol. 2, n. 4, 2005, pp. 297–304; discussion 311–2, DOI:10.1513/pats.200504-043SR, PMID 16267352.
Albertí J, Martinet A, Sentellas S, Salvà M, Identification of the human enzymes responsible for the enzymatic hydrolysis of aclidinium bromide, in Drug Metab Dispos, vol. 38, n. 7, luglio 2010, pp. 1202–10, DOI:10.1124/dmd.109.031724, PMID 20332199.
Sentellas S, Ramos I, Albertí J, Salvà M, Antón F, Miralpeix M, Beleta J, Gavaldà A, Aclidinium bromide, a new, long-acting, inhaled muscarinic antagonist: in vitro plasma inactivation and pharmacological activity of its main metabolites, in Eur J Pharm Sci, vol. 39, n. 5, marzo 2010, pp. 283–90, DOI:10.1016/j.ejps.2010.01.004, PMID 20093184.